PC BLUE POLISH 2 TR BERRY PURPLE PET UV/30% PCR SC 2 PE ACORN BROWN UV 2

REPRIZE - DHP-2 PP PINK TRANS W/PEARL #2 BLUE TONER PET 2

BLACK SMPE 2 UV TRANS PINK MIST 2 TR JASMINE ROSE PET #2

ORANGE ACETAL LM 2 GREY ACETAL LM 2 ANTRACITE GRAY ABS GP22 2

PC/ABS ORANGE 2 MIDNIGHT GREY ABS GP22 2 GRAPHITE GRAY ABS GP22 2

Microsoft PowerPoint - Investor Day 2012_05072012.pptx PolyOne Corporation Investor Day 2012 May 16, 2012 (1) Page 1 Welcome (2) Page 2 • In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

Microsoft PowerPoint - AVNT Q4 2021 Earnings Presentation (v17) - W PEERS x ESI AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 1 R E S U L T S A N D 2 0 2 2 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 8 , 2 0 2 2 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 26 Capex / Revenue 2022E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 4 3 3 5 5 5 7 7 7 A vi e nt A vi e nt ( E xc l.

Crack formation can be an indicator of impending material failure.   This fiber network also helps components resist cooling sink formations in heavy wall sections.

Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life. It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device, including the suitability of all raw materials and components used for its manufacture, and with all applicable laws and regulations. 1.844.4AVIENT www.avient.com

Great Place